Risky Bottom for TRIB 2W TFPrecarious Bottom for TRIB.
It seems TRIB may be cycling up from a downward parallel channel.
cm williams vix fix indicator alludes the Bottom is forming.
SRSI and RSI indicator levels are somewhat healthy.
Risky
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.68USD
−24.02 MUSD
56.83 MUSD
10.96 M
About Trinity Biotech plc
Sector
Industry
CEO
John Gillard
Website
Headquarters
Bray
Founded
1992
FIGI
BBG000C1D008
Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. It operates through the Americas and Rest of World geographical segments. The company was founded by Ronan O'Caoimh and Denis R. Burger in June 1992 and is headquartered in Bray, Ireland.
Trinity Biotech ($TRIB) Spike on Increased TrinScreen HIV OrdersTrinity Biotech plc (NASDAQ: NASDAQ:TRIB ) has captured market attention with a staggering 54.20% premarket surge on Tuesday, driven by robust demand for its TrinScreen HIV product. This significant price action reflects a positive shift in both the company's fundamentals and technical indicators,
TRIB **ON HIGH ALERT**Not only are they crushing EPS. Extremely good chart position falling wedge could break out for a big gain. Definitely watching closely and volume alerts.
$TRIB Breaking outCouple shots on goal here in the near term, mainly accelerating revenue based off existing sales of PCR based COVID tests plus a new 12-min rapid antigen test coming in Feb. This is a turnaround play as the stock was previously priced for bankruptcy. Valuation should be 10-12x sales or $25-$30. P
TRIB BullishIt looks like the 50MA is acting as support and the price is very close to the POC which is also at the .23 fibonacci level The MACD is crossing. First target $4.68
Could be a 10 bagger coming up Seems trade between 2 dollars and 24. Worth taking a shot for a 10 bagger if you are willing to wait for the pattern to confirm
Trinity Biotech In Strong Uptrend Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. It operates through the Americas and Rest of World geographical segments. The company was founded by Ronan O'Caoi
$TRIB ascending triangle (possibly with an FDA/EUA catalyst) COVID-19 plays are very hot ATM. One of the most consistent themes that have the most runners. Trinity Biotech has reported that they have been awaiting approval for EUA from the FDA for their COVID-19 tests called "ELISA" . $trib claims their tests are a lot faster. They've ran up to double digits
TRIB in for a correctionHello,
My Thoughts For You
This chart is showing the weekly timeframe and we can see that there has been a rejection and if we look at the daily TF there has been a rejection 3 times and 4 times on the 4hr TF. I expect a move down is emanant after being rejected on so many time frames.
If you'r
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
T
TRIB4353361
Trinity Biotech Investment Ltd. 4.0% 01-APR-2045Yield to maturity
6.34%
Maturity date
Apr 1, 2045
Explore more bonds